SCHEMBL622342

SCHEMBL622342

O=C([CH]c1ccncc1)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 7/20 0.50
CYP19A1 P11511 6/20 0.50
ALDH1A1 P00352 3/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.46
HSD11B1 P28845 1/20 0.45
EPHX2 P34913 1/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
P2RX7 Q99572 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8068014 0.84 JUN (0.51) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL6092331 0.84 JUN (0.51) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL27837991 0.74 KMT2A (0.62) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL1769996 0.70 MAPT (0.56) CYP17A1CYP19A1KMT2AMEN1HSD11B1
SCHEMBL8077622 0.70 MAPT (0.56) CYP17A1CYP19A1KMT2AMEN1HSD11B1
SCHEMBL1770376 0.67 HSD11B1 (0.54) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL1548224 0.67 CYP17A1 (1.00) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL8075850 0.67 CYP19A1 (1.00) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL12040547 0.67 GABBR2 (0.53) ALDH1A1KMT2AMEN1KDM4ELMNA
SCHEMBL6091145 0.67 GABBR2 (0.53) ALDH1A1KMT2AMEN1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017205786-A1 CELL PERMEABLE PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. (US) 2017-11-30 WO disclosed
WO-2017004548-A1 PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. (US) 2017-01-05 WO disclosed
EP-2603600-A2 PEPTIDOMIMETIC MACROCYCLES Aileron Therapeutics, Inc. (US) 2013-06-19 EP disclosed
WO-2012021876-A2 PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. (US) 2012-02-16 WO disclosed